Description
Ulcerative Colitis is a type of IBD that causes inflammation, sores, and abdominal pain. This clinical trial is being conducted to evaluate the safety and efficacy of an investigational Alfa Induction Therapy in people with Ulcerative Colitis.
Criteria & Qualifications:
• Is at least 18 years of age or older.
• Diagnosed with Ulcerative colitis in the last 3 months.
• Is willing to provide medical records.
• Must have active symptoms, such as rectal bleeding.
Compensation: up to $1,500
